Introductory Price on FDA biomarkers
To celebrate our recent FDA submissions we have a very special offer for our excisting and new customers for the remainder of 2015!
Promising data from type 2 diabetes study
Together with our subsidiary KeyBioscience AG, we are proud to announce the successful completion of our phase I study with our novel Dual Amylin and Calcitonin Receptor Agonist (DACRA) that we currently are developing for type 2 diabetes, obesity and NASH.
Participation in EU funded research project APPROACH
We are very proud to announce our participation in a large scale EU funded research project in osteoarthritis called APPROACH.
Er du vores nye receptionist?
Vi har modtaget mere end 200 ansøgninger til vores receptioniststilling på blot 3 døgn, og af den grund har vi valgt at tage stillingsopslaget ned, idet vi er overbeviste om, at vi vil finde en god kandidat blandt de modtagne ansøgninger.
We're hiring a Business Development Manager
Our business is booming and we are looking for a talented Business Development Manager to join our team in Herlev.